A Phase 2, Open-Label Study of the Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase 2, Open-Label Study of the Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis

Published:2008-07-01 Issue:3 Volume:48 Page:304-309
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Vazquez José A,Schranz Jennifer A,Clark Kay,Goldstein Beth P,Reboli Annette,Fichtenbaum Carl

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference28 articles.

1. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.;White;Clin Microbiol Rev,1998

2. Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.;Fichtenbaum;Clin Infect Dis,2000

3. Options for the management of mucosal candidiasis in patients with AIDS and HIV infection.;Vazquez;Pharmacotherapy,1999

4. Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole.;Kartsonis;J Acquir Immune Defic Syndr,2002

5. Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients.;Masia Canuto;Eur J Clin Microbiol Infect Dis,2000

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population;Expert Opinion on Drug Metabolism & Toxicology;2020-06-07

2. Anidulafungin: a noninferior alternative to fluconazole for treatment of esophageal candidiasis;Clinical Research In Practice: The Journal of Team Hippocrates;2018-08-30

3. Systemic Antifungal Agents;Infectious Diseases;2017

4. Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2016-07

5. Oral fungi in HIV: challenges in antifungal therapies;Oral Diseases;2016-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3